Artwork

Content provided by A Cure In Sight. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by A Cure In Sight or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Getting to Know TScan Therapeutics, guest, Dr. Debora Barton

25:14
 
Share
 

Manage episode 395635816 series 3530258
Content provided by A Cure In Sight. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by A Cure In Sight or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join A Cure in Sight, an ocular melanoma foundation, to interview Debora Barton at TScan Therapeutics.

Tune in for an episode full of hopeful advances in treatment avenues and research.
Check out their website, www.tscan.com for information on their sites open for prescreening as well as their treatment protocol.
You can learn more about the uveal melanoma specific trials at the links below: NCT05812027 (screening protocol) and NCT05973487 (treatment protocol).
Debora Barton, M.D., is the Chief Medical Officer at TScan Therapeutics. Debora, a clinical oncologist experienced in developing cell therapies, brings to TScan nearly two decades of expertise across global clinical research and development. Prior to joining TScan, Debora was the Chief Medical Officer at Carisma Therapeutics Inc., where she was responsible for the clinical development of a First-in-Human, First-in-Class cell therapy, including clinical operations, medical affairs, and safety. Previously, Debora was the Senior Vice President, Head of Clinical, Head of Safety at Iovance Biotherapeutics, Inc., where she built a team to run several Phase 2 studies in solid tumors and led clinical efforts related to regulatory interactions. Prior to Iovance, she held positions of increasing responsibility at biotech and pharmaceutical companies including Advanced Accelerator Applications S.A., Celgene Corporation, and Novartis. Debora is a board-certified clinical oncologist (M.D.), and a board member for the American Cancer Society, the Tigerlily Foundation (medical advisory board), and Arovella Therapeutics Ltd (non-executive director). She holds an M.D. from Pontificia Universidade Catolica Sao Paulo and completed her fellowship in Oncology at Federal University of Sao Paulo in Brazil.

Read a summarized transcript of this episode at the link.

ANNOUNCEMENTS:
Steps for Sight 2024 is underway! Join the steps movement or donate to research January only at www.charityfootprints.com/SFS2024

5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved! Highest record for registrations is 306! Who can top it!? Fundraisers have a record of $30K+ in Palo Alto–who can help beat that!?

January 20, 2024 Orlando FL

https://runsignup.com/Race/FL/Orlando/LookinForACureTampa

January 21, 2024, Miami FL

https://runsignup.com/Race/FL/Miami/LookinForACureMiami
March 24, 2024, Tampa, FL

https://runsignup.com/Race/FL/Tampa/LookinForACureTampaFL

March 30, 2024, Brooklyn, NY

https://runsignup.com/Race/NY/Brooklyn/LookinForACureBrooklyn

May 18, 2024, Raleigh, NC

https://runsignup.com/Race/NC/Raleigh/LookinForACureRaleigh

Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org

COMING OCTOBER 2024: Eye Believe Survivorship Seminar in Scottsdale, Arizona - Join A Cure in Sight and Dr. Justin Moser from Honorhealth Research Institute for our upcoming survivorship seminar in the sunny state of Arizona! Details on registration coming soon!
Subscribe to the newsletter to stay in the know
Newsletter link

Email contact@acureinsight.org for questions regarding any upcoming events!
*********

Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org

  continue reading

155 episodes

Artwork
iconShare
 
Manage episode 395635816 series 3530258
Content provided by A Cure In Sight. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by A Cure In Sight or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join A Cure in Sight, an ocular melanoma foundation, to interview Debora Barton at TScan Therapeutics.

Tune in for an episode full of hopeful advances in treatment avenues and research.
Check out their website, www.tscan.com for information on their sites open for prescreening as well as their treatment protocol.
You can learn more about the uveal melanoma specific trials at the links below: NCT05812027 (screening protocol) and NCT05973487 (treatment protocol).
Debora Barton, M.D., is the Chief Medical Officer at TScan Therapeutics. Debora, a clinical oncologist experienced in developing cell therapies, brings to TScan nearly two decades of expertise across global clinical research and development. Prior to joining TScan, Debora was the Chief Medical Officer at Carisma Therapeutics Inc., where she was responsible for the clinical development of a First-in-Human, First-in-Class cell therapy, including clinical operations, medical affairs, and safety. Previously, Debora was the Senior Vice President, Head of Clinical, Head of Safety at Iovance Biotherapeutics, Inc., where she built a team to run several Phase 2 studies in solid tumors and led clinical efforts related to regulatory interactions. Prior to Iovance, she held positions of increasing responsibility at biotech and pharmaceutical companies including Advanced Accelerator Applications S.A., Celgene Corporation, and Novartis. Debora is a board-certified clinical oncologist (M.D.), and a board member for the American Cancer Society, the Tigerlily Foundation (medical advisory board), and Arovella Therapeutics Ltd (non-executive director). She holds an M.D. from Pontificia Universidade Catolica Sao Paulo and completed her fellowship in Oncology at Federal University of Sao Paulo in Brazil.

Read a summarized transcript of this episode at the link.

ANNOUNCEMENTS:
Steps for Sight 2024 is underway! Join the steps movement or donate to research January only at www.charityfootprints.com/SFS2024

5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved! Highest record for registrations is 306! Who can top it!? Fundraisers have a record of $30K+ in Palo Alto–who can help beat that!?

January 20, 2024 Orlando FL

https://runsignup.com/Race/FL/Orlando/LookinForACureTampa

January 21, 2024, Miami FL

https://runsignup.com/Race/FL/Miami/LookinForACureMiami
March 24, 2024, Tampa, FL

https://runsignup.com/Race/FL/Tampa/LookinForACureTampaFL

March 30, 2024, Brooklyn, NY

https://runsignup.com/Race/NY/Brooklyn/LookinForACureBrooklyn

May 18, 2024, Raleigh, NC

https://runsignup.com/Race/NC/Raleigh/LookinForACureRaleigh

Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org

COMING OCTOBER 2024: Eye Believe Survivorship Seminar in Scottsdale, Arizona - Join A Cure in Sight and Dr. Justin Moser from Honorhealth Research Institute for our upcoming survivorship seminar in the sunny state of Arizona! Details on registration coming soon!
Subscribe to the newsletter to stay in the know
Newsletter link

Email contact@acureinsight.org for questions regarding any upcoming events!
*********

Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org

  continue reading

155 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide